Management of Severe Pediatric Tourette Syndrome Resistant to Drug Treatment

Tourette syndrome (TS) is a neurodevelopmental disorder with chronic and disabling impacts on multiple domains of functioning in children. Treatment of TS is often complicated by comorbid conditions. We present a 12-year-old boy with severe symptoms of Tourette syndrome (TS), with prominent and mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Hemamali, Abayanayaka, Chittahari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461628/
https://www.ncbi.nlm.nih.gov/pubmed/23047460
http://dx.doi.org/10.1155/2012/497160
_version_ 1782245104065445888
author Perera, Hemamali
Abayanayaka, Chittahari
author_facet Perera, Hemamali
Abayanayaka, Chittahari
author_sort Perera, Hemamali
collection PubMed
description Tourette syndrome (TS) is a neurodevelopmental disorder with chronic and disabling impacts on multiple domains of functioning in children. Treatment of TS is often complicated by comorbid conditions. We present a 12-year-old boy with severe symptoms of Tourette syndrome (TS), with prominent and markedly disabling vocal tics, who failed to respond to substantial doses of risperidone and haloperidol, given for a prolonged period. Satisfactory outcome was achieved with exposure and response prevention, adjunct to medication. Comorbid ADHD was treated with stimulants with no exacerbation of tics.
format Online
Article
Text
id pubmed-3461628
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34616282012-10-04 Management of Severe Pediatric Tourette Syndrome Resistant to Drug Treatment Perera, Hemamali Abayanayaka, Chittahari Case Rep Psychiatry Case Report Tourette syndrome (TS) is a neurodevelopmental disorder with chronic and disabling impacts on multiple domains of functioning in children. Treatment of TS is often complicated by comorbid conditions. We present a 12-year-old boy with severe symptoms of Tourette syndrome (TS), with prominent and markedly disabling vocal tics, who failed to respond to substantial doses of risperidone and haloperidol, given for a prolonged period. Satisfactory outcome was achieved with exposure and response prevention, adjunct to medication. Comorbid ADHD was treated with stimulants with no exacerbation of tics. Hindawi Publishing Corporation 2012 2012-09-23 /pmc/articles/PMC3461628/ /pubmed/23047460 http://dx.doi.org/10.1155/2012/497160 Text en Copyright © 2012 H. Perera and C. Abayanayaka. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Perera, Hemamali
Abayanayaka, Chittahari
Management of Severe Pediatric Tourette Syndrome Resistant to Drug Treatment
title Management of Severe Pediatric Tourette Syndrome Resistant to Drug Treatment
title_full Management of Severe Pediatric Tourette Syndrome Resistant to Drug Treatment
title_fullStr Management of Severe Pediatric Tourette Syndrome Resistant to Drug Treatment
title_full_unstemmed Management of Severe Pediatric Tourette Syndrome Resistant to Drug Treatment
title_short Management of Severe Pediatric Tourette Syndrome Resistant to Drug Treatment
title_sort management of severe pediatric tourette syndrome resistant to drug treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461628/
https://www.ncbi.nlm.nih.gov/pubmed/23047460
http://dx.doi.org/10.1155/2012/497160
work_keys_str_mv AT pererahemamali managementofseverepediatrictourettesyndromeresistanttodrugtreatment
AT abayanayakachittahari managementofseverepediatrictourettesyndromeresistanttodrugtreatment

Ejemplares similares